Baird downgraded ARMO BioSciences, Inc. (NASDAQ: ARMO) from Outperform to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Downgrades

BMO Capital Downgrades ARMO BioSciences, Inc. (ARMO) to Market Perform Following TakeoverMay 10, 2018 11:03 AM Leerink Partners Downgrades ARMO BioSciences, Inc. (ARMO) to Market PerformMay 10, 2018 9:20 AM Pre-Open Movers 05/10: (ARMO) (HEAR) (VTVT) Higher; (MDCA) (NUAN) (BKNG) Lower (more...)May 10, 2018 9:14 AM Form SC TO-C ARMO BioSciences, Inc. Filed by: LILLY ELI & COMay 10, 2018 8:05 AM Lilly (LLY) to Acquire ARMO BioSciences (ARMO) for $50/ShareMay 10, 2018 7:31 AM Lilly Announces Agreement To Acquire ARMO BioSciencesMay 10, 2018 7:30 AM